StockMarketWire.com - Regenerative medicine company Collagen Solutions said it had sold its stake in marine biotechnology company Jellagen for around £215,000 to an undisclosed buyer.
Jellagen was focused on developing collagen biomaterials from jellyfish and Colleagen had held a minority stake in the company since 2014.
'We remain interested in Jellagen's progress as it continues to develop its jellyfish collagen cell culture products for the research markets,' chief executive Jamal Rushdy said.
'Our decision to divest our shares does not preclude future potential opportunities to collaborate with Jellagen.'
'We are pleased with our return on this investment, which we can use to further support our own growth opportunities.'
At 1:58pm: [LON:COS] Collagen Solutions Plc share price was +0.05p at 3.8p
Story provided by StockMarketWire.com
Shares Magazine
Shares is the leading weekly publication for retail investors. It is packed with investment ideas, news and educational material to help build and run portfolios and get more from your money.
Investor Events
Shares puts on free Investor Events throughout the year across the country. They provide an opportunity for investors to learn more about companies on the stock market and hear from a range of investment experts including fund managers and Shares journalists.